Promino Nutritional Sciences Inc.
MUSLF
$0.02
$0.00-12.31%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 536.70% | 4,288.24% | 1,057.32% | 14.36% | -38.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 536.70% | 4,288.24% | 1,057.32% | 14.36% | -38.45% |
| Cost of Revenue | 568.88% | 1,379.06% | 38,300.00% | -44.94% | -91.79% |
| Gross Profit | 490.84% | 953.77% | 319.38% | 51.01% | 107.75% |
| SG&A Expenses | -55.95% | -69.66% | -76.46% | -130.05% | 294.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.36% | -57.21% | -71.43% | -111.43% | 5,787.26% |
| Operating Income | 73.06% | 73.81% | 79.22% | 113.91% | -857.84% |
| Income Before Tax | 110.71% | 52.41% | 83.32% | 104.30% | -1,086.15% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 110.71% | 52.41% | 83.32% | 104.30% | -1,086.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 110.71% | 52.41% | 83.32% | 104.30% | -1,086.15% |
| EBIT | 73.06% | 73.81% | 79.22% | 113.91% | -857.84% |
| EBITDA | -- | -- | -- | 114.07% | -837.16% |
| EPS Basic | 108.15% | 77.20% | 92.43% | 101.57% | -1,225.00% |
| Normalized Basic EPS | 76.47% | 78.13% | 92.42% | 100.39% | -1,314.29% |
| EPS Diluted | 107.48% | 77.20% | 92.43% | 101.57% | -1,325.00% |
| Normalized Diluted EPS | 76.47% | 78.13% | 92.42% | 100.39% | -1,314.29% |
| Average Basic Shares Outstanding | 36.49% | 109.84% | 123.88% | 173.76% | -12.99% |
| Average Diluted Shares Outstanding | 36.49% | 109.84% | 123.88% | 173.76% | -12.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |